The University of Bristol has secured a £45million deal to advance its groundbreaking gene therapy technology for chronic kidney diseases. The commitment, made by healthcare company Syncona Ltd to Bristol spin-out Purespring Therapeutics, aims to address a global unmet need for renal conditions in one of the largest single investments made to a new UK university biotech company.
Corticosteroids reduce the risk of death among critically ill COVID-19 patients by 20 per cent, an analysis of seven trials published today [2 September] in the Journal of the American Medical Association (JAMA) has found. The results of three of the trials included in the meta-analysis are also published in JAMA today.
A new genetic cause of neurodevelopmental disorder (NDD) has been uncovered by an international team of researchers. The discovery, published in Nature Genetics [10 Apr] and led by the University of Bristol, the Icahn School of Medicine at Mount Sinai in New York and KU Leven in Belgium, offers diagnostic certainty and hope to potentially thousands of families worldwide who have long been searching for answers.
A new study which aims to understand why some people find walking difficult is looking for volunteers.
Researchers have successfully demonstrated the UK’s first long-distance ultra-secure transfer of data over a quantum communications network, including the UK’s first long-distance quantum-secured video call.
Professor Walterio Mayol-Cuevas in the Department of Computer Science is to chair the IEEE ISMAR, the most prominent academic conference on augmented and mixed reality.
It’s not often a new mass extinction is identified; after all, such events were so devastating they really stand out in the fossil record.
Bristol is part of a major new international project to improve our understanding of severe coronavirus infection in humans. The study, funded by the US Food and Drug Administration (FDA), will analyse samples from humans and animals to create profiles of various coronaviruses, including SARS-CoV-2, which causes COVID-19. The results will help inform the development of new treatments and vaccines to tackle coronavirus infections.
Students from the medical and dental schools of Bristol, Cardiff, Exeter and Plymouth have joined forces to launch a new journal that showcases original research undertaken in world-class laboratories and clinics by fellow students.
An international research collaboration, which includes the University of Bristol, has received funding to discover and accelerate the development of new antibiotics.
